Citadel Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-616,500
| Closed | -$131M | – | 15586 |
|
|
2023
Q3 | $131M | Buy |
616,500
+470,000
| +321% | +$93.9M | 0.03% | 494 |
|
|
2023
Q2 | $28.2M | Buy |
146,500
+29,500
| +25% | +$5.86M | 0.01% | 1540 |
|
|
2023
Q1 | $23.7M | Buy |
117,000
+1,700
| +1% | +$273K | 0.01% | 1759 |
|
|
2022
Q4 | $14.8M | Buy |
115,300
+60,600
| +111% | +$7.82M | ﹤0.01% | 2315 |
|
|
2022
Q3 | $7.49M | Sell |
54,700
-55,400
| -50% | -$9.03M | ﹤0.01% | 3196 |
|
|
2022
Q2 | $19.5M | Buy |
110,100
+68,500
| +165% | +$9.87M | 0.01% | 1870 |
|
|
2022
Q1 | $5.99M | Sell |
41,600
-28,800
| -41% | -$3.9M | ﹤0.01% | 3834 |
|
|
2021
Q4 | $10.9M | Sell |
70,400
-26,100
| -27% | -$4.37M | ﹤0.01% | 2930 |
|
|
2021
Q3 | $16.4M | Buy |
96,500
+22,600
| +31% | +$3.52M | ﹤0.01% | 2293 |
|
|
2021
Q2 | $11.7M | Sell |
73,900
-11,200
| -13% | -$1.66M | ﹤0.01% | 2837 |
|
|
2021
Q1 | $11.8M | Sell |
85,100
-8,200
| -9% | -$1.32M | ﹤0.01% | 2733 |
|
|
2020
Q4 | $16.3M | Buy |
93,300
+15,100
| +19% | +$2.82M | ﹤0.01% | 2027 |
|
|
2020
Q3 | $15.3M | Buy |
78,200
+8,100
| +12% | +$1.36M | ﹤0.01% | 1814 |
|
|
2020
Q2 | $11.9M | Buy |
70,100
+47,900
| +216% | +$7.15M | ﹤0.01% | 2029 |
|
|
2020
Q1 | $2.56M | Sell |
22,200
-3,300
| -13% | -$365K | ﹤0.01% | 3740 |
|
|
2019
Q4 | $2.91M | Sell |
25,500
-81,000
| -76% | -$8.59M | ﹤0.01% | 3821 |
|
|
2019
Q3 | $9.1M | Buy |
106,500
+67,800
| +175% | +$4.97M | ﹤0.01% | 2327 |
|
|
2019
Q2 | $2.68M | Sell |
38,700
-35,300
| -48% | -$2.47M | ﹤0.01% | 4043 |
|
|
2019
Q1 | $5.42M | Buy |
74,000
+44,900
| +154% | +$3.19M | ﹤0.01% | 2886 |
|
|
2018
Q4 | $1.65M | Buy |
29,100
+12,800
| +79% | +$803K | ﹤0.01% | 4458 |
|
|
2018
Q3 | $1.26M | Sell |
16,300
-5,400
| -25% | -$398K | ﹤0.01% | 5150 |
|
|
2018
Q2 | $1.44M | Sell |
21,700
-7,500
| -26% | -$430K | ﹤0.01% | 4611 |
|
|
2018
Q1 | $1.53M | Sell |
29,200
-11,300
| -28% | -$616K | ﹤0.01% | 4146 |
|
|
2017
Q4 | $2.17M | Buy |
40,500
+13,700
| +51% | +$800K | ﹤0.01% | 3527 |
|
|
2017
Q3 | $1.46M | Buy |
26,800
+6,300
| +31% | +$323K | ﹤0.01% | 3799 |
|
|
2017
Q2 | $1.06M | Buy |
20,500
+5,500
| +37% | +$350K | ﹤0.01% | 3997 |
|
|
2017
Q1 | $943K | Sell |
15,000
-3,000
| -17% | -$187K | ﹤0.01% | 4090 |
|
|
2016
Q4 | $950K | Sell |
18,000
-100
| -0.6% | -$6.01K | ﹤0.01% | 3929 |
|
|
2016
Q3 | $978K | Buy |
18,100
+6,900
| +62% | +$327K | ﹤0.01% | 3865 |
|
|
2016
Q2 | $453K | Sell |
11,200
-2,500
| -18% | -$95.1K | ﹤0.01% | 4631 |
|
|
2016
Q1 | $481K | Sell |
13,700
-1,300
| -9% | -$43.7K | ﹤0.01% | 4469 |
|
|
2015
Q4 | $673K | Sell |
15,000
-10,000
| -40% | -$416K | ﹤0.01% | 4086 |
|
|
2015
Q3 | $964K | Sell |
25,000
-12,600
| -34% | -$567K | ﹤0.01% | 3875 |
|
|
2015
Q2 | $1.82M | Sell |
37,600
-12,000
| -24% | -$495K | ﹤0.01% | 3169 |
|
|
2015
Q1 | $1.75M | Buy |
49,600
+700
| +1% | +$23.9K | ﹤0.01% | 3233 |
|
|
2014
Q4 | $1.57M | Sell |
48,900
-7,000
| -13% | -$244K | ﹤0.01% | 3198 |
|
|
2014
Q3 | $2.08M | Buy |
55,900
+28,100
| +101% | +$1.11M | ﹤0.01% | 2810 |
|
|
2014
Q2 | $1.06M | Buy |
27,800
+8,900
| +47% | +$336K | ﹤0.01% | 3414 |
|
|
2014
Q1 | $861K | Sell |
18,900
-11,500
| -38% | -$550K | ﹤0.01% | 3622 |
|
|
2013
Q4 | $1.21M | Buy |
30,400
+1,600
| +6% | +$65.3K | ﹤0.01% | 3032 |
|
|
2013
Q3 | $1.26M | Buy |
28,800
+9,700
| +51% | +$404K | ﹤0.01% | 2859 |
|
|
2013
Q2 | $601K | Buy |
+19,100
| New | +$666K | ﹤0.01% | 3658 |
|
Other funds holding SGEN
SCM
IA
BTI
FBC
VWA
SAG
Citadel Advisors's SGEN Position: Q4 2023 in Review
Citadel Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 2,428,418 shares — an estimated $515M sold.
Citadel Advisors first reported a position in SGEN in Q2 2013 and held it in 39 quarters. The position peaked at $515M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.
- Citadel Advisors reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Citadel Advisors sold 2,428,418 Seagen Inc. Common Stock shares in Q4 2023, an estimated $515M.
- Citadel Advisors first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 39 quarters.
- Citadel Advisors's Seagen Inc. Common Stock position peaked at $515M in Q3 2023.
- 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.